CD19 and Immunodeficiency: Not surprisingly, aberrant CD19 signaling is implicated the development of B cell malignancies, autoimmunity, and immunodeficiency (Barrena et al., 2005; Yazawa et al., 2005; Mei et al., 2012; van Zelm et al., 2006).